COVID-19 Vaccine for Children After MIS-C Appears Safe
A study finds no serious complications following COVID-19 vaccine after multisystem inflammatory syndrome, a rare immune condition.
A study finds no serious complications following COVID-19 vaccine after multisystem inflammatory syndrome, a rare immune condition.
Patient with multisystem inflammatory syndrome in children treated initially with intravenous immune globulin and glucocorticoids had reduced risk for serious short-term outcomes than those treated with IVIG alone.
An NIAID study will enroll at least 250 children and young adults to learn the effects of SARS-CoV-2 and multisystem inflammatory syndrome in children (MIS-C).